Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodiol-Methotrexate for Primary Biliary Cirrhosis
NCT00006168Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jan 1994
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised trial in primary biliary cholangitis (PBC) comparing Methotrexate + Ursodiol with Placebo + Ursodiol (2 arms). Primary endpoints: Effects on symptoms, Results of laboratory tests and 5 more. Started Jan 1994; status: completed.
02
Drugs
methotrexate
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT00006168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006168.